Platelet-type Von Willebrand disease: Three decades in the life of a rare bleeding disorder

被引:33
作者
Othman, Maha [1 ,2 ]
机构
[1] Queens Univ, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada
[2] Laurentian Univ, St Lawrence Coll Collaborat Program, Sr Lawrence Coll, Kingston, ON, Canada
关键词
RIPA; GP1BA; GPIb alpha; Type 2B VWD; Platelet function defects; GLYCOPROTEIN-IB-ALPHA; KOZAK SEQUENCE POLYMORPHISM; VONWILLEBRAND-FACTOR; DIFFERENTIAL IDENTIFICATION; NONIDENTICAL TWINS; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; VARIABLE NUMBER; TANDEM REPEATS; 2B VWD;
D O I
10.1016/j.blre.2011.03.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Almost thirty years has passed since the description of platelet-type von Willebrand disease. Named initially pseudo-von Willebrand disease, this mild mucocutaneous bleeding disorder has an intrinsic defect in platelets rather than VWF. Due to its unique features and its similarity to the more common type 2B VWD, many investigators were intrigued by its nature, pathophysiology and molecular genetics aspects. The challenges to diagnose this disorder have created debate in literature about the best method of discrimination from type 2B VWD. The recent development of the PT-VWD mouse model carries huge potential for further understanding of the disease as well as the platelet defect and its influence on other biological processes. This review provides a basic as well as updated knowledge about the PT-VWD including history, clinical and laboratory features and treatment in addition to the diagnostic challenges with a focus on molecular genetics aspects and PT-VWD research. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 59 条
[1]   Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex [J].
Afshar-Kharghan, V ;
Li, CQ ;
Khoshnevis-Asl, M ;
López, JA .
BLOOD, 1999, 94 (01) :186-191
[2]   Molecular mechanisms of platelet adhesion and activation [J].
Andrews, RK ;
Lopez, JA ;
Berndt, MC .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (01) :91-105
[3]   The glycoprotein Ib-IX-V complex in platelet adhesion and signaling [J].
Andrews, RK ;
Shen, Y ;
Gardiner, EE ;
Dong, JF ;
López, JA ;
Berndt, MC .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) :357-364
[4]   The 14-3-3ζ-GPM-IX-V complex as an antiplatelet target [J].
Andrews, Robert K. ;
Du, Xiaoping ;
Berndt, Michael C. .
DRUG NEWS & PERSPECTIVES, 2007, 20 (05) :285-292
[5]  
Aramaki KM, 1999, AM J HEMATOL, V60, P77, DOI 10.1002/(SICI)1096-8652(199901)60:1<77::AID-AJH15>3.0.CO
[6]  
2-Y
[7]  
Cauwenberghs N, 2000, PLATELETS, V11, P373
[8]  
Corral J, 1998, BRIT J HAEMATOL, V103, P997
[9]   TYROSINE SULFATION OF THE GLYCOPROTEIN IB-IX COMPLEX - IDENTIFICATION OF SULFATED RESIDUES AND EFFECT ON LIGAND-BINDING [J].
DONG, JF ;
LI, CQ ;
LOPEZ, JA .
BIOCHEMISTRY, 1994, 33 (46) :13946-13953
[10]   Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibα complex reveals conformation differences with a complex bearing von Willebrand disease mutations [J].
Dumas, JJ ;
Kumar, R ;
McDonagh, T ;
Sullivan, F ;
Stahl, ML ;
Somers, WS ;
Mosyak, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (22) :23327-23334